IMvigor 210, a phase II trial of atezolizumab (MPDL3280A) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC) Meeting Abstract
| Authors: | Hoffman-Censits, J. H.; Grivas, P.; Van der Heijden, M. S.; Dreicer, R.; Loriot, Y.; Retz, M.; Vogelzang, N. J.; Perez-Gracia, J. L.; Rezazadeh, A.; Bracarda, S.; Yu, E. Y.; Hoimes, C. J.; Bellmunt, J.; Quinn, D. I.; Petrylak, D. P.; Hussain, S. A.; Cui, N.; Mariathasan, S.; Abidoye, O. O.; Rosenberg, J. E. |
| Abstract Title: | IMvigor 210, a phase II trial of atezolizumab (MPDL3280A) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC) |
| Meeting Title: | 2016 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2016 Jan 7-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-01-10 |
| Language: | English |
| ACCESSION: | WOS:000378109100353 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2016.34.2_suppl.355 |
| Notes: | Meeting Abstract: 355 -- Source: Wos |
